Since IL13Rα2 can accept IL13 as the same ligand with type II IL4R and IL13Rα1 complex, we examined whether the phosphorylation level of JAK2 was regulated by knockdown of siRNA against IL13Rα2 in RCC cells. The gene discussed is JAK2; the disease is renal cell carcinoma.